A new age of precision gene therapy
A Schambach, CJ Buchholz, R Torres-Ruiz, K Cichutek… - The Lancet, 2024 - thelancet.com
Gene therapy has become a clinical reality as market-approved advanced therapy medicinal
products for the treatment of distinct monogenetic diseases and B-cell malignancies. This …
products for the treatment of distinct monogenetic diseases and B-cell malignancies. This …
Genome editing in the treatment of ocular diseases
Genome-editing technologies have ushered in a new era in gene therapy, providing novel
therapeutic strategies for a wide range of diseases, including both genetic and nongenetic …
therapeutic strategies for a wide range of diseases, including both genetic and nongenetic …
Перспективные направления в лечении герпетической инфекции глаза
ГХ Зайнутдинова - Точка зрения. Восток-Запад, 2023 - east-west-journal.ru
Аннотация Данный обзор литературы посвящен современной технологии лечения
герпетической инфекции глаза путем редактирования генома вируса. Важность …
герпетической инфекции глаза путем редактирования генома вируса. Важность …
[PDF][PDF] la atención primaria en salud
SRDELOSS CLAUDIA, AP SÁNCHEZ - researchgate.net
la atención primaria en salud Retos e innovación desde las ciencias básicas para la atención
primaria en salud [COORDINADORES] SAÚL RAMÍREZ DE LOS SANTOS CLAUDIA AZUCENA …
primaria en salud [COORDINADORES] SAÚL RAMÍREZ DE LOS SANTOS CLAUDIA AZUCENA …
[PDF][PDF] crispr-Cas: de la investigación básica a la aplicación para la atención primaria en salud
DCS Camarena, EM López, VMM Tapia - la atención primaria en salud - researchgate.net
The crispr-Cas system is a mechanism used by prokaryotes to protect themselves from viral
infections and prevent transfection with plasmids. It comprises a guide rna (ribonucleic acid) …
infections and prevent transfection with plasmids. It comprises a guide rna (ribonucleic acid) …